We are live on
!
Find out more
Vanguard Global Advisers Portfolio holdings
AUM
$215B
This Fund
S&P 500
This Quarter
Est. Return
-1.44%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$187B
AUM Growth
–
Cap. Flow
+$194B
Cap. Flow
% of AUM
104.07%
Top 10 Holdings %
Top 10 Hldgs %
40.78%
Holding
3,683
New
3,683
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$24.8B |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$12.4B |
| 3 |
NVIDIA
NVDA
|
+$9.74B |
| 4 |
Apple
AAPL
|
+$8.35B |
| 5 |
Microsoft
MSFT
|
+$6.8B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.86% |
| 2 | Financials | 11.48% |
| 3 | Communication Services | 7.14% |
| 4 | Consumer Discretionary | 7.01% |
| 5 | Healthcare | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Red Robin
RRGB
$192M
| $16.2K | ﹤0.01% |
+5,541
| New | +$20.8K |
|
3377
Castellum
CTM
$61.8M
| $16.1K | ﹤0.01% |
+27,344
| New | +$24.4K |
|
3378
Cardlytics
CDLX
$24.9M
| $16.1K | ﹤0.01% |
+1,532
| New | +$14.9K |
|
3379
Accuray
ARAY
$33.2M
| $16K | ﹤0.01% |
+41,222
| New | +$25.5K |
|
3380
MAIA Biotechnology
MAIA
$85.2M
| $16K | ﹤0.01% |
+11,401
| New | +$21K |
|
|
SVCO
3381
Silvaco Group
SVCO
$246M
| $15.9K | ﹤0.01% |
+2,244
| New | +$10.1K |
|
3382
TScan Therapeutics
TCRX
$52.8M
| $15.9K | ﹤0.01% |
+15,705
| New | +$16.8K |
|
3383
Prelude Therapeutics
PRLD
$443M
| $15.9K | ﹤0.01% |
+4,636
| New | +$12.2K |
|
3384
AudioEye
AEYE
$100M
| $15.8K | ﹤0.01% |
+2,482
| New | +$18.8K |
|
3385
Acumen Pharmaceuticals
ABOS
$193M
| $15.8K | ﹤0.01% |
+6,684
| New | +$17.1K |
|
3386
eHealth
EHTH
$39.1M
| $15.8K | ﹤0.01% |
+12,226
| New | +$28.3K |
|
3387
VirnetX Holding Corp
VHC
$62.8M
| $15.6K | ﹤0.01% |
+1,123
| New | +$19.9K |
|
3388
Sanara MedTech
SMTI
$314M
| $15.5K | ﹤0.01% |
+905
| New | +$18.6K |
|
3389
Key Tronic
KTCC
$43.1M
| $15.4K | ﹤0.01% |
+5,634
| New | +$16K |
|
3390
Atlantic American Corp
AAME
$29.6M
| $15.3K | ﹤0.01% |
+6,588
| New | +$17.9K |
|
|
SNBR
3391
DELISTED
Sleep Number
SNBR
| $15.3K | ﹤0.01% |
+8,539
| New | +$64.3K |
|
|
GENB
3392
Generate Biomedicines
GENB
$2.01B
| $15.3K | ﹤0.01% |
+1,225
| New | +$15K |
|
3393
Biodesix
BDSX
$253M
| $15.3K | ﹤0.01% |
+1,054
| New | +$13.1K |
|
3394
Century Casinos
CNTY
$36M
| $15.1K | ﹤0.01% |
+10,858
| New | +$16.5K |
|
|
EXOD
3395
Exodus Movement Inc
EXOD
$235M
| $15K | ﹤0.01% |
+2,314
| New | +$27K |
|
3396
Expensify
EXFY
$210M
| $14.8K | ﹤0.01% |
+17,042
| New | +$20.2K |
|
3397
AgEagle Aerial Systems
UAVS
$63.9M
| $14.8K | ﹤0.01% |
+16,355
| New | +$18.7K |
|
3398
Freedom Holding
FRHC
$9.34B
| $14.8K | ﹤0.01% |
+102
| New | +$13.1K |
|
3399
Franklin Wireless
FKWL
$28.6M
| $14.7K | ﹤0.01% |
+3,855
| New | +$15.3K |
|
3400
Heritage Global
HGBL
$37.8M
| $14.6K | ﹤0.01% |
+10,769
| New | +$14.2K |
|
Similar funds
Vanguard Global Advisers's Q1 2026 Portfolio in Review
Q1 2026 is the first quarter with a 13F filing on record for Vanguard Global Advisers, which disclosed 3,683 positions worth $187B. Its ten largest holdings account for 41% of the portfolio.
Its largest position is Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, followed by Financials and Communication Services.
- Vanguard Global Advisers's largest Q1 2026 buy was Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
- Vanguard Global Advisers's ten largest holdings make up 41% of its $187B portfolio in Q1 2026.
- Vanguard Global Advisers disclosed 3,683 positions in Q1 2026, its first 13F filing on record.
Based on Vanguard Global Advisers's 13F filing for Q1 2026, filed 8 May 2026.